Skip to main content
Top
Published in: Acta Neuropathologica 6/2014

Open Access 01-06-2014 | Correspondence

BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma

Authors: Sarah Jane Larkin, Veronica Preda, Niki Karavitaki, Ashley Grossman, Olaf Ansorge

Published in: Acta Neuropathologica | Issue 6/2014

Login to get access

Excerpt

Craniopharyngiomas are epithelial, sellar tumours comprising two subtypes: adamantinomatous (aCP) and papillary (pCP). aCPs contain mutations in CTNNB1, encoding β-catenin: a component of the adherens junction and mediator of Wnt signalling. Reported frequency of CTNNB1 mutations varies widely (16–100 %) [6, 7]. Recently, it was reported that pCPs contain BRAF p.V600E mutations in 95 % of cases [2] and that CTNNB1 and BRAF mutations are mutually exclusive and specific to tumour subtype. We examined the relationship between mutation in CTNNB1 and BRAF and subcellular location of β-catenin in a series of 37 craniopharyngiomas. The region of BRAF exon 15 containing codon 600 was sequenced, as was exon 3 of CTNNB1. Immunohistochemistry (IHC) for β-catenin was used to examine its subcellular location and an antibody specific for the BRAF V600E mutation (clone VE1) was used to complement the sequencing findings in all aCP and pCPs. Methods are reported in Online Resource 1. …
Appendix
Available only for authorised users
Literature
1.
go back to reference Adackapara CA, Sholl LM, Barletta JA, Hornick JL (2013) Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma. Histopathology 63(2):187–193. doi:10.1111/his.12154 PubMedCrossRef Adackapara CA, Sholl LM, Barletta JA, Hornick JL (2013) Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma. Histopathology 63(2):187–193. doi:10.​1111/​his.​12154 PubMedCrossRef
2.
go back to reference Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, Lawrence MS, Rodriguez FJ, Bernardo LA, Schubert L, Sunkavalli A, Shillingford N, Calicchio ML, Lidov HG, Taha H, Martinez-Lage M, Santi M, Storm PB, Lee JY, Palmer JN, Adappa ND, Scott RM, Dunn IF, Laws ER Jr, Stewart C, Ligon KL, Hoang MP, Van Hummelen P, Hahn WC, Louis DN, Resnick AC, Kieran MW, Getz G, Santagata S (2014) Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet 46(2):161–165. doi:10.1038/ng.2868 PubMedCrossRef Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, Lawrence MS, Rodriguez FJ, Bernardo LA, Schubert L, Sunkavalli A, Shillingford N, Calicchio ML, Lidov HG, Taha H, Martinez-Lage M, Santi M, Storm PB, Lee JY, Palmer JN, Adappa ND, Scott RM, Dunn IF, Laws ER Jr, Stewart C, Ligon KL, Hoang MP, Van Hummelen P, Hahn WC, Louis DN, Resnick AC, Kieran MW, Getz G, Santagata S (2014) Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet 46(2):161–165. doi:10.​1038/​ng.​2868 PubMedCrossRef
3.
go back to reference Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, Siebzehnrubl F, Hahnen E, Kreutzer J, Fahlbusch R (2005) Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol 109(6):589–597. doi:10.1007/s00401-005-1004-x PubMedCrossRef Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, Siebzehnrubl F, Hahnen E, Kreutzer J, Fahlbusch R (2005) Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol 109(6):589–597. doi:10.​1007/​s00401-005-1004-x PubMedCrossRef
5.
go back to reference Kato K, Nakatani Y, Kanno H, Inayama Y, Ijiri R, Nagahara N, Miyake T, Tanaka M, Ito Y, Aida N, Tachibana K, Sekido K, Tanaka Y (2004) Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 203(3):814–821. doi:10.1002/path.1562 PubMedCrossRef Kato K, Nakatani Y, Kanno H, Inayama Y, Ijiri R, Nagahara N, Miyake T, Tanaka M, Ito Y, Aida N, Tachibana K, Sekido K, Tanaka Y (2004) Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 203(3):814–821. doi:10.​1002/​path.​1562 PubMedCrossRef
7.
go back to reference Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, Sakamoto M, Hirohashi S (2002) Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol 161(6):1997–2001PubMedCentralPubMedCrossRef Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, Sakamoto M, Hirohashi S (2002) Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol 161(6):1997–2001PubMedCentralPubMedCrossRef
8.
go back to reference Sperveslage J, Gierke M, Capper D, Honegger J, Sipos B, Beschorner R, Schittenhelm J (2013) VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation. Acta Neuropathol 125(6):911–912. doi:10.1007/s00401-013-1118-5 PubMedCrossRef Sperveslage J, Gierke M, Capper D, Honegger J, Sipos B, Beschorner R, Schittenhelm J (2013) VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation. Acta Neuropathol 125(6):911–912. doi:10.​1007/​s00401-013-1118-5 PubMedCrossRef
Metadata
Title
BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma
Authors
Sarah Jane Larkin
Veronica Preda
Niki Karavitaki
Ashley Grossman
Olaf Ansorge
Publication date
01-06-2014
Publisher
Springer Berlin Heidelberg
Published in
Acta Neuropathologica / Issue 6/2014
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-014-1270-6

Other articles of this Issue 6/2014

Acta Neuropathologica 6/2014 Go to the issue